Kentucky’s $42 million allocation for psychedelics research for opioid addiction

Today, Daniel Cameron, Attorney General for the US State of Kentucky, announced that the State will take $42 million from its portion of the Opioid Settlement Funds and use it for psychedelic research, specifically ibogaine for opioid addiction.

AG Cameron will be joined with LrGen Martin Steele and his 501c3 organization Reason for Hope, who was  instrumental in educating Kentucky lawmakers on the policy and reform necessary to advance access…

Read more: